Avian sternal cartilage composition and method of administering

Abstract

Powder compositions, method of preparing the compositions and use of the compositions in treating arthritic joint cartilage diseases. The compositions are orally administered to humans in need of cartilage cell repair in a daily dietary supplement dosage of between about 2,400 mg. and 3,600 mg.

1 - 15 . (canceled)  
     
     
         16  A composition comprising collagen type II and having an average molecular weight of between about 45,000 and 65,000 daltons.  
     
     
         17  The composition of  claim 16  wherein the collagen type II is derived from avian sternal cartilage.  
     
     
         18  The composition of  claim 17  wherein the sternal cartilage is from 4-8 week old chicks.  
     
     
         19  The composition of  claim 16  wherein the collagen type II is mammalian.  
     
     
         20  The composition of  claim 16  wherein the collagen type II is from shark fins.  
     
     
         21  The composition of  claim 16  is in powder form.  
     
     
         22  The composition of  claim 16  wherein the composition includes 65% to 70% collagen type II.  
     
     
         23  The composition of  claim 22  wherein the composition includes 20% to 30% carbohydrate.  
     
     
         24  The composition of  claim 22  wherein the composition includes 1% to 3% lipids.  
     
     
         25  A method for treating an individual with a connective tissue disorder comprising administering to said individual a composition comprising collagen type II and having an average molecular weight of between about 45,000 and 65,000 daltons.  
     
     
         26  The method of  claim 25  wherein the composition is in powder form.  
     
     
         27  The method of  claim 25  wherein said connective tissue disorder is selected from the group consisting of degenerative joint diseases, joint defects, osteoarthritis, polychondritis, vascular disease, cartilage injuries, silicone poisoning, autoimmune diseases, progressive myopia, and menier's disease.  
     
     
         28  The method of  claim 25  further comprising the step of administering the composition in a daily dosage of between about 600 mg. and 10,000 mg.  
     
     
         29  The method of  claim 28  wherein the daily dosage is between about 1,200 mg. and 7,200 mg.  
     
     
         30  The method of  claim 28  wherein the daily dosage is between 2,400 mg. and 3,600 mg.  
     
     
         31  A method of providing a nutritional supplement to an individual comprising administering a composition comprising collagen type II and having an average molecular weight of between about 45,000 and 65,000 daltons.  
     
     
         32  The method of  claim 31  wherein the composition is in powder form.  
     
     
         33  The method of  claim 31  further comprising the step of administering the composition in a daily dosage of between about 600 mg. and 10,000 mg.  
     
     
         34  The method of  claim 33  wherein the daily dosage is between about 3,600 mg. and 7,200 mg.  
     
     
         35  The method of  claim 33  wherein the daily dosage is between about 2,400 mg. and 3,600 mg.